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GENERAL CONCLUSIONS 
       This study gave an idea about the role of domestic dogs in 
transmitting the disease and also points to the importance of the diagnosis 
and genotyping of CVL in the West Bank.  ITS1 PCR-RFLP used for 
species typing with no intra species variation, while the kDNA PCR-
RFLP, utilizing the primer pair Uni 21/Lmj4, was useful to check the 
polymorphism, in this study the microheterogenity was evident among 
the strains tested. The one strain that appeared more different from others 
was IPT1, a human VL isolated from Tunisia. Thus, parasite 
polymorphism may be attributed to variations among parasites from 
different geographical locations or clusters.  
The data presented in this study indicate a successful attempt to satisfy 
the need for a more sensitive, specific, and rapid test for the diagnosis of   
CVL. 
Serological techniques (e.g. ELISA) alone, which are used to estimate the 
infected dog population (Cardoso et al., 1998), are not  a suitable tools for 
diagnosis of CVL, while PCR offers more accurate results. Indeed, the 
sensitivity and specificity of the PCR assay depends on several factors, 
including PCR primers, DNA extraction methods, source of clinical 
materials (Reithinger et al., 2000) PCR target and PCR target molecular 
size as we proved. The advantage of using blood sampling that it is less 
invasive than bone marrow, spleen, or lymph node aspirate, and samples 
can be processed readily. This approach on blood samples has proven 
useful for the diagnosis and monitoring of VL in adults and children in 
the Mediterranean region (Sundar and Rai, 2002).  
Further studies are under way in other VL endemic regions, particularly 
in the southern part of the West Bank, to validate the methodology and to 
evaluate the ability of PCR-RFLP to identify other Leishmania species.   
 
 
 
 
 
 
 
 
Recommendation points  
 We recommend to keep screening the potential reservoirs in the 
Jenin area, in order to eradicate and break the leishmaniasis cycle 
in this region, and to prevent or decrease the HVL incidence in the 
area. 
 Continue spraying insecticides to eradicate the vector. 
 Educate the locals by widening their knowledge of the disease 
using leaflets, seminars, and distributing education materials 
targeting the schools, so the people should know more about the 
disease and prevention methods. 
 Establish a database on the disease for planning and evaluation. 
 Regional clinicians must keep in their mind all infectious agents as 
potentials for abdominal enlargement and fever of unknown origin, 
as VL suspected referring them for Al-Quds University, 
Leishmania Laboratory Center for diagnosis as a reference 
laboratory. 
 Palestinian Ministry of health should consider the Leishmania test 
at referred laboratory and implement appropriate control measures 
in endemic areas.  
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CHAPTER ONE 
INTRODUCTION AND LITREATURE REVIEW 
 
1.1 GENERAL INTRODUCTION 
       Leishmaniasis is a parasitic disease caused by obligatory intracellular 
protozoa of the genus Leishmania family trypanomastidae. These 
parasites are transmitted by the bite of infected female sand flies.    
Leishmaniasis is considered the most divers and complex of all vector 
borne diseases in their ecology and epidemiology since they include more 
than two dozen species of parasite that may infect humans, several 
reservoirs, several vector species, and different foci (Aransay et al., 
2000). Currently, leishmaniasis threatens 350 million people in 88 
countries around the world (Jacobson et al., 2003; Gatti et al., 2004) 
throughout Africa, Asia, Europe, North and South America (Markle and 
Makhoul, 2004). There are an estimated 12 million new cases of 
Leishmaniasis reported each year; 1.5 to 2 million cases of them are 
coetaneous Leishmaniasis and 500,000 are visceral Leishmaniasis (Jaffe 
et al., 2004).  The major clinical forms of Leishmaniasis range from self 
healing cutaneous lesions through metastasizing muco-cutaneous forms 
to potentially lethal visceral forms (Bhattacharyya et al., 1993;  Schonian 
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et al., 1996; Cardoso et al., 1998).  The severity of clinical forms in 
immune competent persons depends mainly on the species or subspecies 
of the parasite (Dedet et al., 1999), the immunologic status of the host and 
his genotype  (Blackwell et al., 2004). 
 
1.2 THE LEISHMANIASIS AS HUMAN DISEASES 
1.2.1 Cutaneous Leishmaniasis (CL) 
       Cutaneous Leishmaniasis (CL), or oriental sore, is usually caused by 
L. tropica, L. major, L. aethiopica in the old world (Berman, 1997) and L. 
braziliesis complex and L. mexicana in the new world (Oumeish, 1999; 
Reithniger et al., 2003). CL may also, however, be caused by any of the 
Leishmania species which infect humans. L. infantum, which causes 
visceral leishmaniasis, has been isolated from skin lesions of „atypical 
cases of cutaneous leishmaniasis‟(Carreira et al., 1995; Martin-sanches, 
2001). The vector for leishmaniasis is the sand fly and the oriental sore 
first appears as a persistent sand fly bite. After the sand fly bite the 
incubation period varies from one week to several months. Gradually the 
lesion enlarges, remaining red, but without heat or pain, furthermore 
complications like secondary bacterial infection can occur, and can affect 
the style of the lesion (Jawabreh, 2001). The lesion resolution involves 
immigration of leucocytes, which isolate the infected area leading to 
necrosis of the infected tissues, and formation of a healing granuloma in 
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the floor of the lesion (Ashford, 2000). Self healing without treatment 
is the rule, but the time taken for healing varies greatly according to the 
species of the parasite and the site of the lesion. Cured patients remain 
immune to homologous infection for many years.   Rarely, leishmaniasis 
cell-mediated immunity fails to develop to the parasite a severe form of 
this disease will develop as a diffused cutaneous leishmaniasis (DFL) that 
may it caused by L. mexicana amazonensis (Salman et al., 1999). This 
form usually starts with primary lesion that progress to numerous lesions 
resembling leprosy, which do not heal spontaneously (Desjeux, 1999). 
 
1.2.2 Mucocutaneous Leishmaniasis (MCL) 
       Mucocutaneous Leishmaniasis is mostly found in Latin America 
(Aviles et al., 1999), but is occasionally reported from Sudan and other 
old world foci (Ashford, 2000).  This form occurs when Leishmania 
invades the mucosal membrane of the mouth, nose and throat, causing 
severe destruction and permanent disfiguring of these organs. The 
causative agents of this leishmaniasis are L. aethiopica in the old world 
and L. brasilliensis in the new world (Mehregan et al., 1999). 
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1.2.3 Visceral Leishmaniasis (VL) 
       Visceral Leishmaniasis, also known in Asia as black fever or kala-
azar, is the most severe form of leishmaniasis and is lethal if not promptly 
diagnosed and treated (Adini et al., 2003; Tintaya et al., 2004). Several 
Leishmania species are present in the foci of VL in the old and new 
worlds such as L. infantum in the Mediterranean region and in Asia 
(Obzel et al., 2000), L. donovani in India and East Africa (Dereure et al., 
2003, b; Elnaiem et al., 2003), and L. chagasi in the new world (Vexenat 
et al., 1998). The parasite invades the reticuloendothelial system of 
internal organ particularly the liver, spleen, bone marrow and lymph 
nodes; the incubation period is ten days to over one year from the sand fly 
bite and the clinical manifestations include fever, malaise, loss of weight 
hypergamaglobulinaemia, hepatosplenomegaly, lymphoadenopathy and 
panacytopenia (Abranches et al., 1991; Rhalem et al., 1999; Gavagani et 
al., 2002).    Occurrences of asymptomatic cases of kala-azar have been 
reported from Kenya, Brazil and India. These persons never give any 
history of symptoms or show any clinical sign of infection (Sharma et al., 
2000). Asymptomatic phases and relapses suggest that the parasite can 
exist in the tissues for a long time before and /or after clinical onset of the 
disease. Two cases of VL have been described in a patient with 
lymphoma and in a pregnant woman (Dereure et al. 2003, a). In both 
5 
 
cases, parasites remained present in the lymph nodes after clinical 
cure for a few months with no parasite clearance.  
 
1.2.4 Post-Kala-azar Dermal Leishmaniasis (PKDL) 
       This form is endemic in Africa and India, and is primarily caused by 
L. donovani. PKDL is an important sequel seen in 10 to 20% of kala-azar  
patients in India (Salman et al., 1999). It appears to be a result of kala-
azar (Kumar et al., 2001), but occasional cases are reported with no 
history of kala-azar (Ashford, 2000). The clinical picture is characterized 
by multiple non ulcerating nodules on the skin of the face, limbs and/or 
trunk (El-Hassan et al., 1995). 
 
1.3 CANINE VISCERAL LEISHMANIASIS 
       Canine Visceral Leishmaniasis (CVL) is a severe systemic disease of 
dogs, generally with a long asymptomatic period followed by a clinical 
period which leads to animal death (Santos-Gomes et al., 2003).         
Clinically, old and new world CVL gives similar symptoms to those of 
human VL (Rhalem et al., 1999). Additional symptoms typicaly found in 
infected dogs are depilation, onychogryposis, and emaciation (Abranches 
et al., 1991). The prevalence of CVL in the Mediterranean region varies 
between 10-37% (Obzel et al., 2000). However, there is evidence that 
infection prevalence rates may be higher than those given by serological 
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studies (Lachaud et al., 2002, b). Reliable diagnostic tests are 
therefore required for the detection of CVL in both clinically ill and 
asymptomatic dogs. 
 
1.4 THE PARASITIC LIFE CYCLE 
       The parasite exists in two morphological forms, the first is as non 
flagellated intracellular spherical amastigote found in its vertebrate host 
and the second is flagellated promastigote found in sand fly species 
(Ashford, 2000; Cunningham, 2002). Throughout their life cycle, 
Leishmania parasites encounter a wide range of environmental conditions 
such as temperature and pH.   Promastigotes survive at an average 
temperature of 26 °C in a mildly basic environment (> 8) in the intestinal 
tract of the sand fly vector, while amastigotes survive temperatures 
typical to mammalian hosts and a pH range of 4.5-6.0 within 
macrophages. (Garlapati et al., 1999). Sand fly females become infected 
during blood meal from infected hosts, they ingest infected macrophages. 
These parasites transform in to sand fly midgut to procyclic 
promastigotes, which then differentiate into infective flagellated 
metacyclic promastigotes. During the next blood meal, the infective 
metacyclic promastigotes are passed in to the vertebrate hosts through the 
puncture wound and are phagocytosed by macrophages which they 
transform back to intracellular amastigotes (Cunningham, 2002). 
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Amastigotes multiply in infected cells which soon lyse releasing large 
number of amastigotes. Those affect different tissues depending on the 
Leishmania species, thereby accounting for the many different clinical 
manifestations of leishmaniasis (see fig. 1.1). 
. 
 
Figure 1.1 shows the Life cycle of Leishmania 
1.5 VECTORS 
       Sand fly vectors belong to the family Psychodidae, subfamily 
phelobotominae (Killic-Kendric, 1999) and are blood sucking insects that 
can be distinguished from other insects by their brownish color, small 
size (1.5-2.5 mm), hairy appearance, long legs, jerk flight pattern 
(Sawalha, 2001) These flies have public health importance since they 
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serve as vectors of etiologic agents of leishmaniasis. The subfamily 
phlebotominae comprises six genera :Worileya, Plebotomus, 
Sergentomyia, Chinius, Brumptomyia and Lutzomyia (Aransay et al., 
1999). The most medically important species belong to the genus 
phlebotomus in the old world and lutzomyia in the new world. Sawalha et 
al. (2003) described the Phlebotomine sand flies as the potential vector of 
leishmaniasis in the Jenin district, West Bank.  Killick-Kendric, (1990) 
noted that of eighty one suspected vector species and sub species only 
nineteen were confirmed. A further fourteen are considered to be strong 
candidates for transmission to humans.  
 
1.6 RESERVOIR HOSTS 
       A reservoir and vectors should share the same habitat in order for the 
disease to be transmitted. In zoonotic CL, the parasite is transmitted from 
animal to man; the primary reservoir host of L. major is Psammomys 
obesus in north and West Africa and western Asia including Jordan, 
Palestine, Israel and Syria (Schlein et al., 1982). The reservoir for L. 
tropica which causes anthroponotic CL and spreads from person to 
person is not well defined. However, L. tropica could also be zoonotic 
since parasites of this species have been isolated from dogs in Kabul, 
Iran, and Morocco (Dereure et al., 1991). Hyraxes are now well 
established as the main reservoir host of L. aethiopica in Ethiopia and 
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Kenya (Ashford, 2000). Hyraxes have also been demonstrated to 
contain the DNA of L. tropica which was detected in the skin and blood 
of hyraxes captured in northern Israel (Jacobson et al. 2003).  In general, 
wild and domestic canids should therefore be considered as possible 
reservoirs for L. infantum, the causative agent of human VL. Humans 
become infected accidentally and do not act as a reservoir hosts for L. 
infantum, except in cases where contaminated syringes are shared among 
intravenous drug addicts (moreno and Alvar, 2002). Among domestic 
animals the dog is the principal reservoir of L. infantum in most countries 
bordering the Mediterranean Sea and through out the Middle East 
(Qubain et al., 1997; Baneth et al., 1998; Dereure et al., 2000), in 
addition, the red fox Vulpes vulpes and the common rat Rattus rattus have 
been infected (Ashford, 1996; Ashford, 1999).   On the other hand, there 
is a growing belief that dogs may also be the main reservoir host of 
American cutaneous leishmaniasis (Reithinger et al., 2003; Ryan et al., 
2003). In the case of anthroponotic VL due to L. donovani such as in 
India, no animal reservoirs have been identified (Elnaiem et al., 2003). It 
is presumed that lesions from PKDL patients act as reservoirs (Singh and 
Sivakumar, 2003). 
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1.7 HIV-LEISHMANIA COINFECTION 
       The co-infection of Leishmania and HIV is emerging as a new and 
frightful disease. Most of the co-infection cases have been reported in 
south –western European countries (Cortes et al., 2004). Where 50% of 
adult VL cases are associated with HIV infection (reviewed by Adini et 
al., 2003).    In Israel, several cases of Leishmania–HIV co-infection have 
been reported (Ya'ari et al., 2004). Visceral leishmaniasis accelerates the 
onset of AIDS and shortens the life –expectancy of HIV-infected people, 
while HIV spurs the spread of VL since the Leishmania parasites and 
HIV destroy the same immune response cells, leading to increase in the 
severity and fatality of the disease (Ya‟ari et al., 2004; Desjeux, 1999). 
 
1.8 VISCERAL LEISHMANIASIS IN PALESTINE AND ISRAEL 
       The first case of VL in Israel was described in 1929 in a 3 years old 
child from Ein Harod in northern Israel. Since then sporadic cases have 
been reported, primarily among Arab communities in Jaffa, Jerusalem, 
Haifa and Nablus districts. Before 1960, most of the patients were not 
hospitalized or their cases not reported, which causes underestimation for 
the prevalence of the disease (Ya‟ari et al., 2004). During the 1960s, 45 
cases of VL were diagnosed from different Arab villages in Gallilee 
(Adini et al., 2003). During the following few decades, however, clinical 
human VL in the Gallilee has declined significantly and where only seven 
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cases were reported from northern Israel in the 1990s (Jaffe et al., 
2004).  Abdeen et al., (2002) have shown that, 50 cases of human VL 
were diagnosed from Jenin district, and 5.5% of the domestic dogs were 
seropositive during 1989-1998. In the same ten year period, 32, 17 and 15 
cases of human VL were also diagnosed in the Hebron, Tulkarm and 
Ramallah districts, respectively. In addition, four cases of human VL 
were reported from Al-muhtasib and Alia hospital, in Hebron during 
2004 (Ahmad Amro, unpublished data).  
 
1.9 CONTROL OF VISCERAL LEISHMANIASIS 
       Some countries where VL is endemic control programs are designed 
to prevent infections in human beings by controlling the vector and 
reservoir.  One of the approaches to reduce the incidence of human VL is 
to cull infected dogs but a Brazilian study showed that killing of 
seropositive dogs is insufficient as a measure for eradicating VL in dogs 
(Ashford et al., 1998). The dog culling programs failed for several 
reasons: first, necessary proportion of infected dogs are not  culled either 
because of miss diagnosis, or non compliance of dog owners (Borja-
Cabrera et al., 2004) second, long delays between sample collection, 
sample analysis, and control implementation, this delay may be as long as 
80 days with infected dogs remaining infectious to sand fly vectors 
(Reithinger et al., 2002) Third, owners quickly replace their dogs with 
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puppies, which are more susceptible to infection (Gavgani et al., 
2002). Treatment of canine leishmaniasis has been an important issue 
since its causative agents are the same as in humans offering the 
possibility of treatment with the same or related drugs; most often 
pentavalent antimonials are used. Treatment of infected dogs with anti-
Leishmania drugs has proved, however, not to be a practical control 
policy because of the high cost and the very high relapse rates of up to 
80% (Vexenat et al., 1998; Moreno and Alvar, 2002; Gavgani et al., 
2002). Protection of dogs by means of topical persistent insecticides in 
collars or by dipping might be effective (Ashford, 1996) and house 
spraying with insecticides used in vector control may also prevent 
infections in human (Sawalha et al., 2001).  Vaccines against canine VL 
represent the main tool for controlling leishmaniasis, in that successful 
immunization of dogs could significantly reduce the incidence of human 
visceral leishmaniasis (Dye, 1996). Borja-Cabrera et al. (2004) reported 
that Fucose Mannose Ligand (FML) vaccine was effective in 
immunotherapy against VL of asymptomatic infected dogs. However, an 
effective vaccine against human and canine- VL is not yet available. 
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1.10 DIAGNOSIS OF LEISHMANIASIS 
       The diagnosis of leishmaniasis is difficult because the clinical signs 
are variable can be caused by a number of other etiological agents leading 
to a potential missdiagnosis (Harris et al., 1998). The need for correct 
diagnosis is the more important because treatment for leishmaniasis is 
very expensive, very lengthy and is associated with toxic side effects 
(Baneth and Shaw, 2002).  
 
1.10.1 Traditional Diagnostic Methods: 
1.10.1.1 Microscopic and Culture Techniques 
       The parasitological diagnosis is the simplest and most commonly 
performed procedure. The diagnosis in VL is based on observation of 
amastigotes in giemsa stained smears of bone marrow, lymph nodes or 
splenic aspirates. Though microscopic examination is rapid, cheap and 
easy to perform, it lacks sensitivity due to the low number of parasites in 
tissue samples and does not distinguish between species (Singh et al., 
1999; Reale et al., 1999; Aransay et al., 2000; Silva et al., 2001). Parasite 
culture can improve the sensitivity in parasite detection, but tissue 
samples from visceral organs are required to initiate cultures and 
obtaining these samples requires a traumatic procedure that has been 
associated with risk of hemorrhage, In Israel, however, Leishmania 
culture was applied in routine clinical practice (Abed Nasereddin, 
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personal communication). They are mainly required for obtaining a 
sufficient number of organisms to use as an antigen for immunologic 
diagnosis (Sundar and Rai, 2002; Iniesta et al., 2002) or obtaining 
parasites to be used in inoculating susceptible experimental animals 
(Abranches et al., 1991; Santos –Gomes et al., 2003; Moreno and Alvar, 
2002) and finally, to provide a diagnosis when routine methods have 
failed. In vitro cultivation needs a sophisticated laboratory setup, are 
time-consuming (Lachaud et al., 2000; Marfurt et al., 2003), harbor the 
risk of contamination and does not allow for species identification. 
1.10.1.2 Skin Testing 
       Leishmania skin test is a test for delayed type hypersensitivity 
specific to leishmaniasis. This method uses 0.5 ml of phenol-killed whole 
parasites (5x10
7
) that are injected on the vola forearm and the iduration 
size is measured after 48-72 hours. A positive test measures induration 
with 5 mm diameter or greater. It is not, however, a species specific test 
and cannot distinguish between active and past infection (Rodriguez et 
al., 1994 ; Delgado et al 1996). 
 
1.10.2 Current Diagnostic Methods: 
1.10.2.1 Serodiagnosis  
       The human body makes an attempt to fight VL by producing some of 
the highest levels of antibodies found in response to any disease. The 
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presence of high levels of antibodies against parasitic antigens can 
simplify diagnosis of VL by serological techniques that detect these 
antibodies.  Enzyme-linked immunosorbent assay (ELISA) has been used 
as a potential serodiagnostic tool for almost all infectious diseases, 
including leishmaniasis. The sensitivity and the specificity of ELISA is 
greatly influenced by the antigen used (Singh and Sivakumar, 2003). 
Several antigens have been tested; the common one is a crude soluble 
antigen (CSA). Cross reactions with sera of patients with other 
trypanosomiasis, tuberculosis, and toxoplasmosis, have been recorded 
(Belli et al., 1998; Reithinger et al., 2003). Furthermore, ELISA 
sensitivity and specificity could be increased by the use of soluble 
antigens derived from promastigotes cultivated in a protein free medium 
(Romero et al., 2004). A recombinant antigen, rK39, derived from L. 
chagasi has also been shown to be specific for antibodies in a patient with 
VL caused by members of the L. donovani complex (Sundar and Rai, 
2002). It was previously shown that anti-rK39-titers were 59-fold higher 
than those of antibody against CSA at the time of diagnosis, and with 
successful therapy, it fell sharply at the end of treatment and during 
follow-up monitoring. ( Kumar et al., 2001). Practically, because of the 
condition prevailing in areas of high endemicity, there is a need for a 
simple, rapid and accurate test with high sensitivity and specificity, which 
can be applied by any laboratory technician. Immune chromatographic 
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dipstick test based on rK39 antigen has been developed as a rapid test 
for use in difficult field condition. Carvalho et al. (2003) confirmed the 
accuracy of antigen strip test in the diagnosis of VL in Brazil, the 
sensitivity and specificity were 90% and 100%, respectively. Finally, 
specific antibodies can also be detected by western blotting, 
promastigotes of Leishmania parasites were grown to log phase and 
lysed, the soluble protein is subjected to electrophoresis, the separated 
proteins are blotted onto nitrocellulose sheets and probed with serum 
from the patient, western blotting find minor antigenic differences among 
various organism (Aisa et al., 1998) but the process is time consuming 
and expensive. 
1.10.2.2 Polymerase Chain Reaction (PCR) 
       Serology is an inefficient method to differentiate active and past 
cases and the fact that culture of Leishmania cells is laborious method 
with low sensitivity (De Brujin et al.,1993) creates a diagnostic obstacle 
that can be, perhaps solved by the application of the DNA detection 
method. PCR development has provided a powerful approach to the 
application of molecular biology techniques to the diagnosis of 
leishmaniasis, and is a simple tool that has proven to be more specific and 
sensitive than conventional diagnostic methods (Ashford et al., 1995).   
Primers have been designed to amplify several DNA targets for 
Leishmania, such as; the minicircle Kinetoplast DNA (kDNA) (Smyth et 
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al., 1992; Noyes et al., 1998), the small subunit rRNA gene ( ssu 
rRNA ) ( Pizzuto et al., 2001; Lemarni et al., 2002), the mini exon gene 
sequences ( Harris et al., 1998; Marfurt et al., 2003), a repetitive genomic 
sequences ( Piarroux et al., 1995), internal transcribed spacer (ITS) 
(Schonian et al., 2003; Strauss-Ayali et al., 2004) and the Leishmania 
antigens gene locus e.g. surface metalloprotease glycoprotein 63 (gp63) 
encoding gene (Guerbouj et al., 2001; Mauricio et al., 2001; Tintaya et 
al., 2004). Mitochondrial Kinetoplast DNA is one of the most unusual 
DNA structures with double stranded DNA  minicircles and maxicircles, 
catenated together into a single giant network of DNA situated adjacent 
the basal body of flagellum.  The minicircle Kinetoplast DNA (0.8 to 1Kb 
in length) is an ideal target since it is present in 10,000 copies per cell. In 
addition, its sequence is known for most Leishmania species; also it 
possesses a variable region that offers accurate discrimination between 
species (Bozza et al., 1995).  A variety of clinical samples, including 
bone marrow, spleen, lymph nodes, skin and conjunctiva biopsy 
specimen as well as whole blood samples have been used for diagnosis. 
PCR done from blood spots on filter paper can also be used as a screening 
test to identify Leishmania infection in humans or dogs (Campio et al., 
2000; Franca –silva et al.,2003; Da-silva et al., 2004; Cortes et al., 2004). 
Moreover, PCR with peripheral blood was considered as a more reliable 
method for diagnosis of VL in HIV-infected patients (Lachaud et al., 
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2000; Pizzuto et al., 2001) since the sensitivity of antibody detection 
method in these patients is very low (Vilaplana et al., 2004).  In a study 
reported from Israel, PCR using non invasive conjunctiva samples was 
found to be more sensitive (92%) than either PCR using other tissues 
(17%-77%) or detection of parasites in culture (74%) (Strauss-ayali et al., 
2004). Several PCR methods with a wide range of sensitivities and 
specificities have been described (Piarroux et al., 1994; Osman et al., 
1997). A PCR- (ELISA) technique using a primer that was able to 
identify 33 L. infantum strains from 19 different zymodeme has been 
developed. It has sensitivity higher than that of other traditional 
diagnostic techniques (Martin-Sanches et al., 2001). This PCR-ELISA 
technique can be used for diagnosis of VL from peripheral blood samples. 
 
1.10.2.3 Hybridization using kDNA probes  
       DNA-DNA hybridization technique is very useful in the 
classification of Leishmania parasites. The molecular basis for DNA 
hybridization is based on the use of a labeled single standard DNA 
sequence, selected from well-characterized reference species, to hybridize 
with homologous DNA from, unknown isolates of parasites.  The first 
study of a DNA sequence identification  was reported from India, in 
which a specific probe cloned from minicircle DNA of Leishmania strain 
UR 6 (MHOM/IN/1978/UR6) reacted only with a strain of PKDL but not 
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with strains or isolates of VL (Gupta et al., 1991). Also a species –
specific DNA probe from L. infantum has been generated (Reale et al., 
1999). DNA hybridization has been employed to detect and identify 
leishmanial infection in sand fly vectors (Barker, 1989). Da Silva et al. 
(2004) showed that the sensitivity of PCR was increased from 71.7% to 
83.5% when the technique was combined with molecular hybridization; 
all the PCR products were confirmed as L. chagasi after hybridization 
with a minicircle probe cloned from the same species.  
 
1.11 SPECIES AND STRAIN IDENTIFICATION 
       Species identification is important because different species require 
distinct treatment (Marfurt et al., 2003).  Furthermore, Characterization of 
Leishmania parasite is also necessary for epidemiological objectives, and 
for designing appropriate control measures (Volpini et al., 2004). 
Different degrees of intraspecies variations were observed in Leishmania 
parasites. However, these variations range from small or lacking in L. 
infantum to large highly observed in L. tropica (Schonian et al., 2001; 
Jacobson et al., 2003; Schnur et al., 2004; Schwenkenbecher et al., 2004). 
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1.11.1 Excreted Factor (EF)  
       Excreted factor (EF), which is a negatively charged carbohydrate-like 
substance obtained from in vitro cultures, was shown to precipitate by 
double diffusion in contact with homologous sera of promastigote-
infected rabbits (Romero et al., 2004). Three serotypes exist A, B and 
AB, and L. infantum gives only the B-serotype reaction (Schnur and 
Zuckerman, 1977). These serotypes are divided in to subserotypes and are 
specific identifiers for different species, and thus this method permits the 
minimal characterization of strains. 
1.11.2  Multilocus Enzyme Electrophoresis (MLEE). 
       Characterization of Leishmania is usually based on multilocus 
enzyme electrophoresis of cultured promastigotes. It is classically 
considered that variation due to isoenzymes reflect neutral mutation 
(Guerbouj et al., 2001) thus the enzyme profiles produced by different 
migration rates allow for species identification. MLEE revealed a broad 
enzymatic polymorphism within the species L. infantum. So far, more 
than 20 different Zymodemes have been described.  Some of them have a 
large geographic distribution such as MON-1 which is the most frequent 
zymodeme in VL patients and infected dogs in the Mediterranean region 
(Martin-Sanchez et al., 2004). All L. infantum strains isolated in Israel 
and Palestine resemble MON-1 zymodemes (Lee Schnur, Personal 
communication) except for one human strain isolated from El-yamon in 
21 
 
Jenin district, which showed a new zymodeme profile (MON-281) 
(Bader et al., 2005 in press). Although several studies used isoenzyme 
analysis to identify Leishmania parasites (Romero et al., 2001; Lemrani et 
al., 2002; Franca-silva et al., 2003; Schnur et al., 2004), this technique 
requires prior cultivation and is time consuming since each isolate must 
be examined by multiple enzyme reaction (Andersen et al., 1996). 
1.11.3 Advanced Molecular Technique: 
1.11.3.1 Permissively Primed Intergenic Polymorphic-PCR 
       Eisenberger and Jaffe (1999) have developed a permissively primed 
intergenic polymorphic (PPIP)-PCR, which uses the specific intergenic 
Leishmania primer 2B and the non leishmanial primer 2A. This technique 
can distinguish between the old world Leishmania complexes. Moreover 
it discriminates between strains of the same species isolated from distant 
geographical regions. 
1.11.3.2 Random Amplified Polymorphic -PCR 
       Random Amplified Polymorphic DNA (RAPD), based on fragment –
length polymorphism, has the advantage that it does not require prior 
knowledge of specific DNA sequence for primer design. This method 
gives a variety of amplification products that are sensitive enough to 
show Leishmania species specificity and to identify isolates derived from 
geographically diverse regions (Schonian et al., 1996; Noyes et al., 1998; 
Mauricio et al., 1999). The disadvantage is that non specific primers are 
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able to amplify non target DNA from host and/or other contaminating 
organisms present in the sample (Eisenberger and Jaffe, 1999) and result 
in sensitivity much lower than that of standard PCR (Harris et al., 1998). 
 
1.11.3.3 PCR- Restriction Fragment Length Polymorphism (PCR-
RFLP) : 
       Parasite identification by RFLP is based on digestion of amplified 
kinetoplast or nuclear DNA with restriction endonuclease followed by 
visualization of the resulting pattern using gel electrophoresis. Recently, 
several PCR-RFLP methods that differentiate Leishmania species by the 
digestion of different amplified targets have just been described 
(Schonian et al.,  2003; Marfurt et al., 2003;Volpini et al.,  2004; Tintaya 
et al., 2004).  Schonian et al. (2003) distinguished all medically relevant 
Leishmania species by digestion of the ITS1 amplicon with the restriction 
enzyme Hea III. In another study reported from Switzerland, in which 
miniexon PCR-RFLP assay was used, this new genotyping method was 
able to differentiate new and old world leishmanial species (Marfurt et 
al., 2003).  Tintaya et al. (2004) developed two new PCR-RFLP assays 
that target the gene locus of an important Leishmania antigen cycteine 
proteinase B (cpb). The assays allowed direct genotyping of parasites in 
bone marrow aspirates and venous blood samples obtained from patients 
with VL. 
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STUDY OBJECTIVES AND SIGNIFICANCE: 
The main objectives of the study are: 
1.  Evaluate the use of PCR as a diagnostic tool for canine leishmaniasis. 
2. Isolate and identify Leishmania parasites from potential reservoirs 
present in the northern part of the West Bank. 
3. Detect polymorphism between local and regional isolates of L. 
infantum by PCR-RFLP based genotyping assay. 
4. Evaluate the sero-prevalence of CVL in the northern part of the West 
Bank. 
Significance 
Domestic dogs have been suspected to be potential reservoirs for VL in 
the northern part of the West Bank. It is hoped that this study will: 
 Provide empirical evidence about the correlation between dogs as 
reservoirs and humans as accidental hosts by employing traditional 
and advanced techniques; 
 Detect genetic polymorphism between different L. infantum strains 
which are may be attributable to different geographical location; 
 Investigate the utility of PCR as a diagnostic tool for CVL 
specifically, on canine blood and to compare serological analysis 
with 3 types of PCR assays which use different DNA targets. 
 In addition analyze their advantages and drawbacks for routine 
diagnosis or epidemiological use. 
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CHAPTER TWO 
MATERIALS AND METHODS 
 
2.1 STUDY AREA 
2.1.1 West Bank 
       The west Bank is bordered by Israel from the north, west , south, and 
the Jordan River and the Dead sea form a natural border with Jordan from 
the east. It is a hilly region, divided in to 10 districts with a mediterrnean 
climate. Approximately 27% of the inhabitants lived in urban 
communities with the remaining people present in rural areas and 
involved in agriculture.   Most of residents live in houses built of concrete 
and or/ stone, many of these houses were constructed in the peripheral 
areas, and  domestic animals like sheep, goats, chickens, and dogs are 
common. Four districts in the northern part of the West Bank including 
Tubas, Tulkarm, Nablus and Jenin districts were chosen for sample 
collction in this study (fig. 2.1). 
2.2 PARASITES 
      Most of the Leishmania strains used in this study were obtained from 
dogs and humans from different regions in Israel and the West Bank 
(table 2.1). 
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Figure 2.1 show the main cities in dark spots that samples collected. 
http://www.arij.org/atlas. 
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Table 2.1 Details of the strain used in this study 
WHO LRC 
Designation 
 
Species 
 
International Code 
 
Origin 
LD1 
L
. 
in
fa
n
tu
m
 
MCAN/PS/2004/LQU-D1 Domestic, Jenin, Palestine 
L773 MHOM/PS/1999/LRC-L773 Human , IVL*, Jenin, Palestine 
L806 MCAN/PS/2000/SawalhaK56 Domestic dog, Jenin, Palestine 
L693 MCAN/IL/1996/LRC-L693 Domestic dog, Nili, Israel 
IPT1 MHOM/TN/1980/IPT1 
a
Human IVL, Tunisia 
L782  
L. tropica 
MHOM/PS/2000/GOKS17 Human CL*, Jenin, Palestine 
L36 MHOM/IQ/1966/BRAYL75 Human CL, Baghdad, Iraq 
L747 ISER/IL/1998/LRC-L747 Ph. Sergenti, Kfar Adumim 
L137  
L. major 
MHOM/PS/1967/Jericho II Human CL, Jericho, Palestine 
5ASKH MHOM/IM/1973/5ASKH Human CL,WHO* 
 
*IVL= infantile visceral Leishmaniasis: CL=Cutaneous Leishmaniasis. 
a
WHO international reference strain. 
 
2.3 DOG POPULATION 
       Domestic dogs were surveyed by house-to-house visits. None of the 
dogs belong to a recognizable breed and all were guard dogs. The dog's 
age ranges from six months to seven years. 148 dogs were sampled, 20% 
(30) of them were females, and 80% (118) were males. 
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2.4 CANINE SAMPLES 
       Peripheral blood samples (10 ml) from 148 domestic dogs, were 
taken by venipuncture, 5 ml into sterile EDTA- tubes for buffy coat 
preparation, and 5 ml in plain tubes for ELISA testing, EDTA-blood 
samples were also spotted on filter paper and preserved at 4ºC as a back 
up samples. The blood was centrifuged at 3000 rpm for 15 min; the buffy 
coat layer (~300 µl) separated, and washed with an equal volume of 
phosphate buffered saline (PBS) (pH 7.4). Sera and buffy coat were 
stored at –20 until use. Seropositive dogs were re-visited, both bone 
marrow and splenic aspirates were obtained and cultured for parasites. 
 
2.4.1 Direct Examination of Smears  
       Smears of peripheral blood were fixed with absolute methanol for 
five minutes, stained with giemsa stain, and the slides were examined 
under high power (100X) with a standard light microscope. 
Approximately 50 microscopic fields were examined for the presence of 
Leishmania like amastigots. 
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2.4.2 Culturing, Freezing, and Parasites Maintenance 
       Bone marrow aspirates and biopsy samples from spleens were 
cultured, immediately after aspiration; into a semi solid blood-agar 
medium Supplemented with 10% rabbit blood. Promastigotes from 
positive cultures were grown in Schneider's Drosophila medium (SDM) 
supplemented with 10% inactivated fetal calf serum (FCS), 2mM L-
glutamin, 200µg/ml penecillin and 200 µg/ml streptomycin (Schnur and 
Jacobson, 1987). These cultures were incubated at 26 ºC and checked 
microscopically every week until promastigotes were observed. A culture 
was considered negative after five weeks of observation. Cultured 
parasites were centrifuged at 3000 rpm for 15 min, washed three times 
with PBS pH 7.2, and then resuspended in 1 ml SDM containing 15% 
glycerol, cooled for one hour on ice, and then frozen at –70 ºC until use. 
 
2.5 ENZYME LINKED –IMMUONOSORBENT ASSAY (ELISA) 
2.5.1 Crude Soluble Antigen and ELISA Plates Preparation 
       Promastigotes of L. infantum isolated from Jenin district were used as  
antigen . These promastigotes were cultured in 40 ml SDM then 
harvested by centrifugation (3000 rpm for 15 min) at a concentration of 
about 5x10
7
 promastigote/ml. The pellet was washed three times with 
PBS and maintained on ice, then resuspended in ice cooled lysis buffer 
(0.2M EDTA ,pH 8.0, 1 M Tris-base,( pH 7.3), 2 M NaCl, X1 Protease 
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inhibitor cocktail (sigma, USA cat. P2714) ) 1 ml lysis buffer /8 ml 
parasite culture, and kept at –70ºC as aliquots. The relative protein 
concentration of the soluble antigens used for coating  ELISA-micro-titer 
well was estimated by measuring the optical density (OD) at 280 nm 
(Peterson, 1983) using the lysis buffer as blank. The antigen protein 
concentration adjusted to 100 µg/ml PBS containing 0.1% thimerosal 
with a 50 µl dispensed per well ( 5 µg/well), then the plates were 
incubated at 4C
o
 for 8-16 hours, washed four times with washing solution 
(1% Tween-20, 0.01% thimerosal in X1 PBS, pH 7.2). The washing 
solution was completely discarded by blotting on tissue paper, 200 µl of 
blocking solution (2% FCS, 0.01% thimerosal in PBS, pH 7.2) added. 
Again the plates were incubated for 3-8 hours at 4C°, washed three times 
with washing solution  and stored at –20 until use (Baneth et al., 1998) . 
2.5.2 Determination of the Cut-off Value 
       One test serum from a microscopically confirmed human case of 
leishmaniasis from Hebron, one positive control serum from a dog 
confirmed with VL microscopically from Israel and 20 negative human 
reference sera, collected from Abu-Deis village presumed to be non 
endemic for leishmaniasis (disease has not been reported), were tested at 
two dilutions (1:100 and 1:1000 ) to determine the cut-off value and its 
corresponding dilution (1: 100 dilution was chosen in order to increase 
the sensitivity of the test). 50 µl of each diluted serum were added in 
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duplicate to the coated wells. The plates were incubated for 1 hour at 
37ºC, washed three times with 0.1% Tween –20 in 50 mM PBS (pH 7.2), 
incubated with protein A conjugated to horseradish peroxidase  (1:8000 
dilution; Zymed Laboratories, Inc., San Francisco, CA) for one hour at 
37C
o
. Excess conjugate was removed by extensive washing (four times) 
in PBS-Tween  and the plates were developed by addition of 1X 100 µl 
of substrate 2,2‟-azino-di-3-Ethylbenzthiazolihne sulfonate (ABTS) 
(Boerhinger Manneheim, Germany). After incubation for 10 minutes at 
room temperature in the dark, optical density was measured at 405 nm by 
a Rosys anthos ELISA reader (Wals, Austria). 
 
2.5.3 ELISA Sero-Survey 
        148 study dogs' sera were diluted 1:100 with PBS, the pre-
determined dilution that corresponded to the cut-off value and assayed in 
duplicate for positivity as described in section 2.5.2., negative 
blank(PBS), known negative and positive controls were included in each 
run to exclude any plate variation.  
 
2.6 DNA EXTRACTION METHOD 
      phenol chloroform DNA extraction method was done as described by 
Schonian et al., (1996). The parasite cultures were pelleted at 2500 rpm 
for 15 min, washed and resuspended three times with PBS (pH 7.4), 
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centrifuged at 3000 rpm for 10 min, and finally frozen at -70C° until 
processing. Frozen or newly prepared parasites were re-suspended in lysis 
buffer ( 50 mM NaCl, 10mM EDTA, 50mM Tris –HCl (pH 7.4)). 
Sodium dodecyl sulfate (SDS) and ribonuclease (RNase) were added to a 
final concentration of 0.5 % and 100 µg/ml, respectively. The mixture 
was incubated for 30 min at 37C°.
 
Then proteniase K was added to a 
concentration of 100 µg/ml, the incubation was continued over night at 
60C
o
 with gentle mixing. The DNA solution was extracted with an equal 
volume of buffered phenol (Sigma, USA), and centrifuged at 3000 rpm 
for 15 min. The upper phase was transferred to fresh tubes, followed by 
addition of a phenol-chloroform-isoamyl alcohol mix (v/v 25:24:1), 
mixed gently and centrifuged for 5 min at 3000 rpm . The upper phase 
was again transferred to fresh tubes, and one volume of chloroform –
isoamyl alcohol (v/v, 24:1) was added, the mixture was vortexed and 
centrifuged at 3000 rpm for 10 min. DNA was precipitated with a final 
concentration of 0.3M sodium acetate (pH 6.0) and 100% isopropyl 
alcohol (Finkelman LTD, Israel)(1:1 cold), mixed gently, and placed on 
ice for 15 min, centrifuged for 30 min at 14,000 rpm. The isopropanol 
was removed and the DNA pellets were washed with cold 70% ethyl 
alcohol (Finkelman LTD, Israel) and centrifuged at 14,000 rpm for 15 
min. The ethyl alcohol was removed and the DNA was dried in  a 
vacuum pump (eppendorf concentrator 5301) and dissolved in 100µl TE 
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buffer (10mM Tris-HCL (pH 8), 1mM EDTA) then stored at -20ºC 
until use. 
 
2.7 STRAIN CHARACTERIZATION AND IDENTIFICATION 
2.7.1 Molecular Characterization  
        PCR-based DNA analysis was done by targeting both nuclear and 
kinetoplast DNA. 
2.7.1.1 The internal transcribed spacer 1 (ITS1)-PCR 
       Primers LITSR (5‟-CTG GAT CAT TTT CCG ATG-3‟) and L5.8S 
(5‟-TGA TAC CAC TTA TCG CAC TT-3‟) are both used to target the 
ribosomal internal transcribed spacer 1 (ITS1) region lying between the 
genes coding for the ssu rRNA and 5.8srRNA gene (El Tai et al., 2001; 
Schonian et al., 2003). Amplification reactions were performed in volumes 
of 50 µl, containing ammonium sulfate buffer X1 (75 mM Tris HCl, pH 
8.8, 20mM (NH4)2So4, 0.01% Tween 20 ) 1.5 mM MgCl2, 1µM of each 
primer, 0.25mM of each deoxy ribonucleoside triphosphates, 2U of 
fermantas recombinant Taq DNA polymerase (MBI Fermantas ,Germany), 
2µl of isolated DNA were added to a reaction mixture. Samples overlaid 
with 50µl mineral oil and amplified in a thermocycler (Gene Amp PCR-
system 9700) programmed for denaturing step, 5 min at 95 ºC  followed by 
35 cycles; denaturing step 1 min at 95ºC; annealing step: 1 min at 53ºC and 
primer extension at 72 ºC for 1 min followed by a final extension of 72 ºC 
33 
 
for 6 min. Amplification products were added to Bromophenol blue 
(BPB) (1mM EDTA pH 8.0, 50% glycerol ) loading dye, then subjected to 
electrophoresis in 1.2%  LE Seakem agarose at 120 V in X1 TAE (1.0 M 
Tris acetate, 0.5M EDTA, pH8.0) buffer. 100 bp DNA ladder was used as 
a molecular size marker (Promega, Madison, WI). The gels were stained 
with ethidium bromide (0.25 µg/ml) and visualized under UV light for 
analysis. 
2.7.1.2 RFLP analysis of the ITS1-PCR 
       This was done according to (Schonian et al., 2003). PCR products 
were digested with HaeIII endonuclease restriction enzyme (Promega, 
Madison, WI) without purification. 10 μl final volume of reaction 
containing: 1μl of X1 enzyme buffer (100 mM Tris-Hcl pH 7.9, 500 nM 
NaCl, 100mM MgCl2 and 10 nM DTT), 0.1 μl Bovine serum albumin 
(BSA), 1 μl of Hae III enzyme and 8 µl of PCR product used. Samples 
were incubated at 37ºC for 2-3 hours. The restriction fragments were 
mixed with BPB and subjected to electrophoresis in 2.5 % metaphore 
agarose (FMC BioProduct, Rockland, MN), containing 0.005% gel star 
stain, at 100v in X1 TAE buffer. 
2.7.1.3 Kinetoplast DNA-PCR using Uni21/Lmj4 primers 
     Oligonucleotide primers Uni21 (5‟-GGG GTT GTT GTA AAA TAG 
GCC-3‟) and Lmj4 (5‟-CTA GTT TCC CGC CTC CGAG-3‟), based on a 
minicircle sequence of L. major, were used to amplify kDNA from 
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cultured promastigotes ( Anders et al., 2002).   Reaction mixtures (50 
µl) contained X1 buffer (10mM Tris-HCl pH 8.8, 50 mM KCl, 0.08% 
Nonidet  P 40 ), 1.5 mM MgCl2 , 0.2 mM of each deoxyribonucleoside 
triphosphate, 1μM of each primer, 2U of Ampli Taq DNA polymerase 
(Perkin-Elmer-cetus, Norwall, CT), 2µl of DNA, amplification was 
performed in a thermocycler (Gene Amp PCR-system 9700) programmed 
for first denaturing step of 5 min at 95ºC, and 35 cycles of: 30 sec at 94 
ºC
  
50 sec at 60ºC , and 1.0 min at 72ºC followed by 7 min at 72ºC as 
final extension. The products were added to BPB loading dye and 
analyzed by electrophoresis in 1.2% agarose gels. 100 bp DNA ladder 
was used as size marker. 
 
2.7.1.4 RFLP analysis of KDNA-PCR products 
       The generation of RFLP profiles of kDNA was done as described by 
(Abdeen et al., 2002). 17μl of PCR product were subjected to restriction 
with Rsa1 and HpaII enzymes (promega, madison, WI). Digestion 
conditions and documentation was done as described in section 2.7.2.2 
except for, an extra 1μl of the enzyme was added for extra 30 minutes as 
boost to insure a complete digestion.  
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2.7.1.5 Data analysis 
       The PCR and RFLP for the leishmanial strains were analyzed using 
the RAPDistance Package  ver. 1.04 (http://WWW.anu.edu/BoZo/software/). 
All Bands obtained were numbered using the Binary system scoring 1 for 
presence and 0 for absence of bands. Similarities representing the ratio of 
shared bands among the total bands of all the L. infantum strain tested. A 
tree was built using distance-matrix (Neighbor-joining), based on pair 
wise comparisons and using DIC Coefficient. The Evolutionary tree 
constructed based on  kDNA- RFLP analysis using 2 different restriction 
enzymes. 
2.8 VALIDATION OF PCR ASSAYS FOR CVL DIAGNOSIS  
2.8.1 Kinetoplast DNA –PCR using 13A/13B primers: 
       The primer pair 13A (5'-GTG GGG GAG GGG CGT TCT- 3') and 
13B (5'-ATT TTA CAC CAA CCC CCA GTT-3'), based on the 
conserved region of the leishmanial kDNA minicircle yeilding 120 bp 
product (Reale et al., 1999). Reactions were performed in 25μl containing 
X1 buffer (10mM Tris-HCl, pH 8.3, 1.5mM MgCl2, 25mM KCl), 1µM of 
each primer, 0.4mM of each dNTP, 2Uof Taq DNA (MBI Fermantas, 
Germany) and 2.5 μl of DNA extraction product. The following 
conditions were applied: initial denaturation at 95 ºC for 5 min followed 
by 35 cycles consisting of denaturation at 95 ºC for 1 min, annealing at 
60 ºC  for 1 min and extension at 72ºC for 1.5 min followed by 7 min of 
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72 ºC for final extension. PCR samples were electrophoresed, using 
2.5% LE Seakem agarose and visualized under ultraviolet light after 
staining in eithdium bromide. 
 
2.8.2 Modified internal transcribed spacer 1 (mITS1) 
      In an attempt to enhance the sensitivity of ITS1-PCR, we recently 
modified the ITS1- PCR assay; this was done by choosing a new 3' 
Primer 100 bp up stream of the old 3'- primer site, there by shortening the 
target sequence to about 200 bp instead of 300 bp.  (fig. 2.3). 
 
 
 
 
 
 
 
Fig. 2.3 Schematic representation of the internal transcribed space (ITS1) in 
the ribosomal operon and the position of newly designed primer (blue arrow) 
used in this study to amplify the mITS1 sequence. Primer sequences are given 
in the text . 
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2.8.2.1 Alignment and primer design  
       DNA sequences of ITS1 region of several Leishmania species were 
obtained from Gene Bank (www.ncbi.nlm.nih.gov/Blast/GeneBank). Using  
nucleotide to nucleotide BLAST search the ITS1 sequences were aligned 
to each other, we focus on L. infantum, L. major, L. tropica since our 
target area was the northern part of the West Bank, where these three 
species coexisted. For that, three ITS1 sequences from three different 
regional Leishmania species were chosen (L. infantum AJ000289.1, L. 
tropica AJ000301.1, and L. major AJ000310.1) and aligned to each other 
using BCM Search Launcher: Multiple Sequence Alignments web site 
(searchlauncher.bcm.tmc.edu/multi-align/multi-align.html). The new primer 
sequence was chosen due to its presence in the 3 species, absence from  
the polymorphic region of each species, and the presence of  Hae III 
restriction sites between opposing primers that are important to provide 
different profile on the gel for each leishmania speceis. A theoretical cut 
was applied to modified ITS1 sequences of all three Leishmania species 
using NEB cutter. Ver. 2 program (http://tools.neb.com/NEBcutter 
2/index.php.). 
.   
2.8.2.2 mITS1-PCR 
       Amplification reactions were performed in volume of 50 µl using the 
previously described LITSR primer as a forward primer and our newly 
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designed primer RmITS1 (5' AAA ACC GAA ACG CCG TA) as a 
reverse primer. Specific amplification and digestion conditions were as 
described by Schonian et al., (2003). 
 
2.8.3 Comparison of Diagnostic Tools and Statiatical Analysis 
       Of the 97 dog sample collected from Jenin District, 60 samples were 
randomly chosen for detection of leishmanial infection by ELISA and 3 
different PCR methods:  kDNA, ITS1, and mITS1 PCR, in order to 
evaluate the use of PCR as a diagnostic tool for CVL, which would allow 
the reliable detection of Leishmania DNA from peripheral blood samples. 
ELISA test , kDNA, ITS1, and mITS1-PCR were done as described 
above.   Statistical analysis was done using SPSS program  ver. 10. 
(Chicago, IL, USA), and the on-line statistics calculator at 
(http://www.graphpad.com/quickcalcs/index.cfm). The agreement between 
diagnostic methods was assessed; also the sensitivity and specificity of 
each method were compared with the golden standard test.  
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CHAPTER THREE 
 
RESULTS 
 
3.1 PARASITE CULTURES 
 
       Ten seropositive dogs were reexamined for clinical signs of the 
disease and subject to biopsy to check for the presence of parasites. 
Among them 3 (30%) were symptomatic, with the external signs of 
leishmaniasis (hair and weight loss and onychogryposis), and 7 were 
asymptomatic (70%) without any external signs.  Out of seven spleen 
cultures, two were positive (28.6%), one was isolated from Qabatiya 
village in Jenin district, then identified, the other being contaminated by 
fungi, while three seropositve dogs did not undergo a biopsy due to 
refusal of the dogs‟ owners. 
 
3.2 MICROSCOPY RESULTS  
       Microscopic examination of peripheral blood smears showed that 
only one out of 60 smears (1.7%) have amastigotes. The amastigotes 
appeared as pale blue oval bodies with dark blue nucleus, and a small 
point shaped kinetoplast (see fig. 3.1).  
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        Intracellular Leishmania amastigote 
 
 
 
 
Fig. 3.1 Experimentally amastigotes infected macrophages, Photo by A. Nasereddin 
 
 
3.3 ELISA-SEROSURVEY 
3.3.1 Determination of the cutoff value 
       Using the crude soluble antigen, the cutoff value, the lower limit of 
positivity, was established as the mean OD + 3 SD of the negative 
controls this was o.4 OD, values above this were positive. The cutoff 
value was established with a serum dilution of 1:100 in PBS. 
 
3.3.2 Sero-Survey 
       The sera of 148 dogs from Tubas, Nablus, Tulkarm, and Jenin 
districts, in the northern part of the west Bank, were tested. Ten of them 
were ELISA positive, (fig. 3.2) indicating a sero prevalence of (6.8%). 
Nine out of 97 dogs sera collected from six villages in the Jenin district 
were sero positive dogs indicating a sero prevalence of (9.2%). One dog 
out of 17 (5.9%) was seropositive from Tulkarm district. 15 and 19 dogs 
were seronegative from Tubas and Nablus respectively. Figure 3.3 shows 
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the correlation of HVL cases in northern West Bank reported by the 
Palestinian Ministry of Health over 9 years (1990-1999) to canine VL 
according to districts seroprevalence, where Jenin had 39.3% of HVL 
with our dog seroprevalence 9.2%, followed by Tulkarm with human 
cases 13.3% and our dog seroprevalence was 5.9%, lasting with 0% dog 
seroprevalence in both Tubas and Nablus, where human cases 2.4% in 
both areas.  
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                                                      Dog samples 
 
Fig. 3.2 ELISA survey for anti-Leishmania anti bodies of domestic dogs, the arrow 
indicates the cut off value.  
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Fig 3.3 Show the association of HVL cases with respect to seropositives dogs in the four districts.   
 
3.4 STRAIN IDENTIFICATION AND GENOTYPING 
3.4.1 Serological and Biochemical Characterization 
         The Excreted factor (EF) and the Zymodeme  analysis were done by 
Schnur L.F. (Hebrew University-Hadassah Medical school, Israel) and 
Dedet J.P (Universite' de Montpellier, France) respectively. The        
strain Li-QUD1 (LD1) was EF sub-serotype B2 in compatibility with the 
serotyping of WHO L. infantum reference strain (MHOM / TN/80/IPT1).  
Zymodeme analysis profile of strain (LD1) using fifteen enzymes showed 
it was MON-1 and identical to IPT1 (table 3.1). Together these analyses 
indicate that strain (LD1) is L. infantum With profiles identical to all 
HVL and CVL strains isolated and analyzed in the region, except for one 
strain isolated from a human (Bader et al., 2005, in press) show faster 
MDH mobility with zymodeme MON-281.  
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Table 3.1  The enzyme profiles of strain MCAN/PS/2004/LQU-D1.(LD1) 
Enzyme Profiles 
 
Zymodeme 
MDH ME ICD PGD G6PD GLUD DIA NP1 NP2 GOT1 GOT2 PGM FH MPI GPI 
MON-001 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
 
 
3.4.2 ITS1-PCR analysis  
       Fig. 3.4.A show the result of ITS1-PCR analysis, This PCR assay 
identifies Leishmania at the genus level. All Leishmania strains in this 
study produced a single band approximately 300 base pair (bp) as 
expected by ITS1-PCR. 
 
3.4.3 ITS1-PCR-RFLP 
       The major advantage of the ITS1-PCR is that species identification 
can be achieved by digestion of the PCR product with restriction enzyme 
Hae III. Thus, all clinically important species can be distinguished by 
their RFLP-pattern. When ITS1-PCR products were digested with Hae 
III, the banding patterns of all L. infantum strains differed from those of 
L. major (L173) and L. tropica (L36, L782) strains. While they were 
identical to L. infantum pattern of the WHO reference strain 
MHOM/TN/80/IPT1, L. tropica (L36, L782) strains have identical 
patterns, but its profile was easily distinguishable from L. major (Fig 
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3.4.B). Both L. infantum and L. tropica are coexisting in Jenin district 
(Sawalha et al., 2003), for that L. tropica included in this study, also 
because L. tropica ability to infect dogs reported in Morocco and other 
localities (Dereure et al., 1991). L693 proved to be L. infantum from 
previous study (Abdeen et al., 2002). 
 
A 
 
 
 
 
B 
 
 
 
 
 
Fig. 3.4 Comparison of the ITS1-PCR amplification products using the primers L5.8S 
and LITSR (A) ITS1-PCR digestion with the endonuclease HaeIII (B). Negative 
PCR: PCR with water added instead of Leishmanial DNA. 
 
3.4.4 kDNA-PCR analysis using LMJ4/UNI21 primers 
       Under the experimental conditions described in materials and 
methods, the kDNA amplification products from the human isolate L773 
and three canine VL strains LD1, L807, and L693 all were aligned with 
one another and with the reference Strain of IPT1 (fig. 3.5). L137 and 
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L36 strains, both were excluded from this kDNA-PCR since the 
ITS1-PCR proved that they are not correlated with L. infantum as 
described above .These strains produced a clear band at the level of 780 
bp. 
 
 
 
 
 
Fig. 3.5 The PCR product of the kDNA, run in 1.5% LE Seakem agarose and visualized under 
ultraviolet light after staining in ethidium bromide. 
 
3.4.5 kDNA-PCR-RFLP analysis 
    The RLFP pattern using the Hpa II endonuclease enzyme shows 
variation between all of the L. infantum strains, significant difference 
pattern was observed between the IPT1 strain from Tunisia and the 4 
samples from Palestine and Israel regions (fig. 3.6) 
 
 
 
 
 
 
 
 
Fig. 3.6 shows the kDNA-RFLP patterns of several L. infantum strains following 
digestion with Hpa II 
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The generated profile of the Rsa I endonuclease enzyme also showed 
obvious variation between the all L. infantum strains. LD1, L773 and 
L807 show 82% shared bands. L693 (data not shown) show high 
homology with the Palestinian strains. 
The total same bands shared between all the strains were 45%. Three 
extra bands appeared in the Tunisian strain and show major differences 
while only minor differences noticed in the rest of the strains (fig. 3.7). 
 
 
 
 
 
 
 
 
 
 
Fig. 3.7 the kDNA-RFLP patterns of (L807, IPT1, L773, and LD1) following 
digestion with Rsa I. 
 
3.4.6 The dendrogram analysis 
       The dendrogram in (fig. 3.8) presents the intra-relationship of various 
strains of L. infantum according to their RFLP patterns using two 
different restriction enzymes. Two main clusters were observed and the 
strains within each cluster showed further intra-specific micro 
47 
 
heterogeneity. The IPT1 strain from Tunisia shows about 80% 
homology with the others. While the strains from Palestine together 
display 95% homology. 
 
Palestine 
 
 
Palestine 
 
 
 
Palestine 
 
 
Tunisia     
 
Fig. 3.8 Evolutionary tree constructed based on KDNA- RFLP analysis using 2 
different restriction  enzymes). The geographic origin of the strains is indicated. The 
numbers on the branches indicate patristic distances while in square brackets indicate 
patristic distances to individual out group. 
 
 
3.5 VALIDATION OF THE PCR ASSAYS FOR CVL DIAGNOSIS 
 
3.5.1 Sequence analysis of mITS1 region and reverse primer design 
       Sequence analysis of the mITS1 region of L. major shows high 
identity with mITS1 region from both L. infantum and L. tropica. The 
most significant homology was observed between 190 to 210 bp and part 
of this sequence was therefore selected as the modified primer for the 3' 
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region for the mITS1-PCR. The identified sequence was (5‟TAC 
GGC GTT TCG GTT TT) and its reverse complementary sequence was 
RmITS1 (5'AAA ACC GAA ACG CCG TA), which was used for PCR 
reaction (fig.  3.9). 
The primer was 17 bases in length with a content of 50% GC, the 
annealing temperature fits that of the forward primer LITSR and both 
primers lack any complementarities to each other. The primer allowed 
generation of a PCR product ~200 bp when it was applied on purified 
DNA from cultured promastigotes of different Leishmania species (fig. 
3.10), as well as on peripheral blood samples obtained from domestic 
dogs.  On the other hand, the amplified mITS1 sequence showed 
polymorphic regions according to Leishmania species, which allows 
species identification by RFLP analysis. The obtained RFLP pattern by 
Hae III digestion of mITS1 amplicon of all Leishmania species, used in 
this study, revealed distinct RFLP profile for each species with no 
geographical differences observed in the same species, for that we 
included local strains L. infantum (LD1), L. major (L137), L. tropica 
(L747) and L. tropica (Goks17), also WHO references strains were 
included as L. major (5ASKH) and L. infantum (IPT1) (fig. 3. 11. A).   
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Fig.  3.9 Multiple alignment of 200bp of the ITS1 (mITS1) for old world Leishmania 
species  
 
 
 
 
 
 
 
 
 
Fig. 3.10 200bp product of mITS1-PCR, applied on local and WHO leishmanial 
strains 
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  A)                                             
     
                                             
                                             
 
B)                                        5    37   41  45   24  
 
 
 
 
Fig. 3.11 The mITS1-RFLP patterns of (5ASKH, L137, LD1, IPT1, L747, Gocks17) 
(A) and dog‟s blood samples (B) following digestion with Hae III restriction 
endonuclease  
 
3.5.2 Sensitivity of ITS1and the mITS1-PCR assays 
       Following the  DNA titration of WHO Leishmania reference strain 
(LRC-L137) from 200ng-0.2fg DNA concentration measured by the 
NanoDrop
®
 ND-1000 UV-Vis Spectrophotometer (NanoDrop 
Technologies, Delaware, USA) we succeeded to amplify the ITS1 
product using purified Leishmania DNA down to 200 pg DNA 
concentration in a 50 µl PCR reaction using LITSR/L5.8S primer pair, 
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while LITSR/RmITS1 primer pair was found to be more sensitive 
with sensitivity of a bout 200 fg. (fig. 3.12) 
         
 
 
 
A  
 
 
B  
 
 
Fig. 3.12 Purified DNA titration of L. major (LRC-137) from 200 ng down to 0.2 fg 
using LITSR/L5.8S primers (A) and LITSR/RmITS1 primes (B)  
 
3.5.3 Comparison of several diagnostic tools for CVL 
       Out of 60 suspected cases, 13 infections were detected by kDNA-
PCR (21.7%)(fig. 3.13), 9 (15%) were positive by mITS1, 5(12%) were 
seropositive by ELISA, and 3(5%) were detected by ITS1-PCR (fig. 
3.14), to identify the infecting species, amplified ITS1 and mITS1 were 
cut by restriction enzyme Hae III, all three ITS1- and nine mITS1-PCR 
positives proved to be belong to L. infantum species (fig. 3.15 and fig. 
3.11.B). Because no single test serve as gold standard, an ideal test that 
would identifiy all infected dogs, for Leishmania test from peripheral 
blood against, which the different assays could be evaluated. Therefore, 
assessment of test performance was based on the assumption that: a dog 
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was confirmed  positive, when one assay was positive for 
Leishmania, and considered as confirmed negative if all the four assays 
were negative (Marfurt et al., 2003). These confirmed values were used 
as the “gold standard” against which each individual diagnostic assay was 
measured. 
 
 
 
        
 
 
 
 
Fig 3.13 kDNA-PCR products  using the primer pair 13A/13B (1-16, dogs samples) 
Lane 5,7-9,11,15,16, +ve samples; Lane 17, +ve control; Lane 18, –ve control; M, 
100 pb DNA ladder.  
 
 
 
 
 
 
 
Fig. 3.14 The ITS1-PCR products using LITSR / L5.8S primers (Lane 1-17, 42-58 
dog samples) Lane 4, +ve sample (dog 45); Lane 18, +ve control; Lane 19, -ve 
control; M, 100pb DNA ladder.  
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Fig 3.15 Digestion of ITS1 amplicon with restriction endonuclease Hae III: 37,41,45, 
Leishmania infected dogs samples characterized as L. infantum. 
 
Results obtained from each assay were compared, as expected the entire 
diagnostic assay were highly specific for the diagnosis of VL. Using 
kDNA-PCR (table 3.2) 13 and 45 samples were identified as true 
positives and negatives, respectively. kDNA-PCR had the highest 
sensitivity of any individual assay, while missing 2 samples identified as 
positives by ELISA. The positive predictive value (PPV) was 97% 
indicates that, there was 97% chance that the result was true positive 
leaving 3% that it was false positive, the negative predictive value (NPV) 
was 96% indicates that, there was 96% chance that the result was true 
negative, leaving 4% chance that it was false negative. The level of 
agreement between kDNA-PCR and the confirmed results, K± standard 
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error (SE), k=0.907±0.064 was excellent, kappa coefficient is the 
agreement between two tests where 0 is chance agreement and 1 is 
perfect agreement. The mITS1-PCR correctly diagnosed 9 true positives 
and 45 true negatives with 6(10%) false negatives. it has a good 
sensitivity with PPV 95%, and the NPV was 88%. The overall agreement 
was good (k±SE= 0.692± 0.110).  
ELISA serology was somewhat better than the ITS1-PCR giving 45 true 
negative, 5 true positive and 10 (16.6%) false negatives that were 
identified as positive by at least one PCR assay. The PPV for the ELISA 
assay was 92% and the NPV was 82%. Agreement between the 
confirmed results and ELISA was moderate, (k±SE=0.429±0.135). The 
ITS1-PCR gave the poorest result of any of the assays used (table 3.2) 
only 3/15(20%) were correctly diagnosed by this PCR with 12 false 
negatives. The sensitivity was very low, PPV and NPV, 87% and 79% 
respectively. The agreement between the ITS1-PCR and the confirmed 
golden standard was only slight, (k±SE=0.273±0.129). No DNA product 
was observed in any assay of the negative control PCRs. 
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Table (3.2): show ITS1-, mITS1-, kDNA-PCR and ELISA results against the 
confirmed results. 
 
 Confirmed Results Total PPV% NPV% Kappa* 
Negative Positive 
ITS1 Negative 45 12 57 87 79  
0.273±0.129 Positive 0 3 3 
Total  45 15 60 
ELISA Negative 45 10 55 92 82  
0.429±0.135 Positive 0 5 5 
Total  45 15 60 
mITS1 Negative 45 6 51 95 88  
0.692±0.110 Positive 0 9 9 
Total  45 15 60 
kDNA Negative 45 2 47 97 96  
0.907±0.064  Positive 0 13 13 
Total  45 15 60 
 
*All kappa calculations show highly significant (P<0.001). 
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CHAPTER FOUR 
DISSCUSION 
 
4.1 PARASITES CULTURE AND MICROSCOPY 
       In this study, of 7 culture attempts in the field only one was 
successful. This was due to problems with contamination (aseptic 
techniques in the field were not ideal as in the equipped laboratory) other 
problems were concerned with the conservation of adequate media, and 
with the maintenance of the optimal temperature under field conditions. 
Although the microscopic technique is rapid and very simple it has low 
sensitivity, probably due to low concentration of parasites in peripheral 
blood (Le Fichoux et al., 1999; Reithinger et al., 2002 ). Only one out of 
60 smears confirmed positive for amastigotes for that, we exclude the 
microscopic examination from the comparison of diagnostic tools. 
However, neither direct examination of smears nor cultures may offer 
adequate sensitivity (Gatti et al., 2004) 
 
4.2 SCREENING OF THE DOGS’ SAMPLES BY ELISA 
       To investigate the role of domestic dogs as a potential reservoir for 
Leishmania parasites in the northern part of the West Bank, We sampled 
148 dogs residing in four districts northern Palestine (Tubas, Jenin, 
Tulkarm, and Nablus). ELISA data presented in this study demonstrated 
that (6.8%) of domestic dogs residing in these areas have been infected 
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with Leishmania, this seroprevalence is identical to Baneth study 
(1998), where his total seroprevalence was 6.8% of his tested dogs in 
Central Israel.  It must be stressed that the positive result from ELISA are 
not related with active parasitic infection (Iniesta et al., 2002). This 
technique detects host-produced antibody to the parasite antigens. Indeed 
antibody response in the host can be extremely variable and can depend 
on immunological status of the host being sampled. However, the 
meaning of asymptomatic but seropositive dogs undoubtedly, indicates 
previous contact with the parasite, but we don‟t know whether these dogs 
will subsequently develop the disease, or if they are only carriers. We 
know from other studies that when host inhabit disturbed environments 
where a natural cycle of Leishmania transmission takes place it can result 
in dramatic increase in disease incidence (Desjeux et al., 2001), it was 
clear from our work in these districts, particularly in Jenin where 9.2% of 
domestic dogs were seropositive , that nearly  every household has at 
least one dog,  the sero prevalence presented here was higher than 5.3% 
obtained in Jenin using a smaller numbers of dogs (Abdeen et al., 2002). 
However, the prevalence of CVL in the Mediterranean region varies from 
1-37% with the infection rates increasing in some foci and disappearing 
in others (Baneth et al., 1998), so the total seroprevalence (6.8%) 
obtained in our study fits within this range. Those exposed dogs may 
present a source of living parasite to sand fly vector, and the close 
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association between human and dogs may be a risk factor for the 
increase in HVL in those areas. Since the annual prevalence of CVL in 
endemic regions frequently fluctuates and can vary among adjacent 
villages, additional surveys are needed in order to establish the trend of 
CVL in this region. However, this study suggests that there may be a 
correlation between the percentage of HVL cases in northern Palestine 
and the prevalence of CVL. Jenin district had the highest percentage of 
both HVL and CVL cases followed by Tulkaram, Tubas and Nablus. 
While more work is needed to confirm this correlation. This study 
demonstrates that the prevalence of Leishmania infection in Jenin district 
is higher than assumed and 70% of seropositive dogs were asymptomatic 
while 30% of them were symptomatic with external signs of 
leishmaniasis ( hair and weight loss and onychogryposis) and may act as 
reservoirs for parasite transmission to sand flies.  This information is 
essential to keep screening  in this area for designing  and implementing 
appropriate control measures since the inhabitants are predominantly with 
a low –income rate who can't depend on expensive treatment for their 
infected  dogs.  
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4.3 CLINICAL SAMPLES 
       Our primary objective was to evaluate the use of PCR assay using 
peripheral blood to detect Leishmania in dogs, indeed this type of 
sampling has the advantages of being much less invasive, easily 
repeatable, and more acceptable to dog owners than bone marrow or 
lymph node collection. We also chose to work with the buffy coat portion 
since the Leishmania is an intracellular parasite of monocytes and 
macrophages and this approach has been validated in humans (Lachuad et 
al., 2000). Nevertheless, the DNA extraction methods from peripheral 
blood had to be optimized in order to reduce inhibition of PCR, which 
was probably due to certain factors such as EDTA and hemoglobin that 
remained after DNA extraction and blocked the PCR reaction ( Hartman 
et al., 2005). In our study the results of kDNA-PCR-based testing of 
peripheral blood samples (using 13A/13B) were particularly encouraging 
(table 3.2), and allowed diagnosis based on routine samples of peripheral 
blood. We found that blood samples are a reliable clinical material type 
for the detection of Leishmania DNA by kDNA-PCR and this observation 
is in agreement with previous reports (Reale et al., 1999; Ikonomopoules 
et al., 2003).  
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4.4 SPECIES IDENTIFICATION AND GENOTYPING 
       L. infantum has been recognized as the most homogenous 
Leishmania species, while in our study the micro-heterogenity was 
readily demonstrable despite their very small number and restricted 
geographical region studied. However, all Old World CL strains (L. 
major and L. tropica) proved different from the L. infantum by using the 
ITS1-PCR RFLP, so we excluded them from kDNA analysis. At the same 
time ITS1-PCR RFLP showed no differences on the species level, while 
it was useful for Leishmania species typing. Micro heterogeneity was 
identified by kDNA-RFLP analysis by using 2 restriction enzymes (RsaI, 
Hpa II). Enzyme boost dose and two enzymes used on the same kDNA-
PCR template proved stability and reproducibility of the cuts, in order to 
avoid inhibition or incomplete digestion. However, the kDNA PCR using 
Lmj4/Uni21 primers (fig. 3.5) and ITS1-PCR/RFLP (fig 3.4) analysis did 
not detect differences between L. infantum strains tested, so they were 
excluded from the genotyping analysis. Using Rsa I kDNA-RFLP 
analysis, the IVL isolate L773 from El-Yamon was also notably different 
from LD1 strain, which was from the next village Qabatiya and more 
similar to L807 isolated a few years ago from the same village El-yamon, 
this results give explanation that both originating from the same locality, 
and excluding the time effect. The dog strains themselves were not 
identical. The difference between the 2 strains from the same village is 
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noteworthy because they were collected from the same village with 
reservoir differences (L773 strain from infantile VL, L807 strain from 
Canine VL). The local strains, show high similarity (95%) by the pattern 
of the bands, while the Tunisian strain showed plus /minus bands on the 
gel, with high percentage of differences (20%) in comparison to the local 
ones. All above data was analyzed by constructing the evolutionary tree, 
heterogeneity and homology was obvious on that tree. The dendogram 
divided the strains in to 2 clades, placed L807, LD1, and L773 in one 
cluster, separating them from the Tunisian one, within the local strains 
LD1 and L807 show higher homology.  The IPT1 appeared more 
different from the other strains used in this study, since it was isolated 
from Tunisia, the very far geographical range. The kDNA variation in 
RFLP analysis show lots of bands due to high number of kDNA 
minicircles. This study focus on VL disease in Palestine and uncover the 
disease dynamic, explaining the activation of latent foci with specific 
genotype due to human integration into the Leishmania life cycle 
(human-host-vector), this happen as a result of human civilization, 
building new settlements (Desjeux et al., 2001), and invading new areas 
unknown to be endemic. In conclusion, this study identifies the causative 
agent of CVL and compares it with local and reference WHO strains. 
CVL causative agent proved to be L. infantum by several traditional and 
advanced techniques. EF, zymodeme analysis and ITS1-PCR proved it is 
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the same species of parasite circulating in the Mediterranean area and 
responsible for CVL and HVL.  
 
 
4.5 EVALUATION OF THE mITS1-PCR FOR DETECTION 
LEISHMANIAL DNA 
       We turned our attention to the ITS1-PCR results since several 
laboratories depend on this assay for VL diagnosis, for that we recently 
developed the mITS1-PCR by shortening the PCR product to ~200 bp 
using our newly designed 3‟ RmITS1 primer as described previously in 
materials and methods. The results of mITS1-PCR came as a surprise 
when applied on pre measured different concentrations of purified 
leishmanial DNA since we  could detect PCR product down to 200 fg, 
corresponding to one parasite (Vitale et al., 2004), while the sensitivity of 
ITS1-PCR was only about 200 pg. Thus, by decreasing the DNA template 
to 200 bp instead of 300 bp we successfully enhanced the sensitivity by a 
factor 10
3
, these results supported by application of our approach on 
peripheral blood samples obtained from domestic dogs, nine CVL cases 
were detected by  the mITS1-PCR, while three cases only detected by 
ITS1-PCR this increased the sensitivity three fold. Our assay has proven 
to be highly specific, with a sufficient sensitivity, also has ability to 
differentiate between Leishmania species by RFLP analysis. Therefore, 
we recommend the use of mITS1 in laboratories that rely on ITS1-PCR 
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for VL diagnosis and species identification, since our newly 
developed assay may detect additional cases that otherwise remain 
undetected by ITS1-PCR.  
 
4.6 COMPARISON OF DIAGNOSTIC METHODS 
       With the aim of finding the most efficient method for detecting 
the leishmanial DNA, we compared three PCR assays with a serological 
assay (ELISA), and assessed their sensitivities and specificities. A 
number of studies have compared PCR diagnosis, with conventional 
diagnostic techniques for VL. These studies have shown that kDNA-PCR 
is significantly more sensitive than the conventional parasitological 
methods (Reale et al., 1999; Ikonomopoules et al., 2003). However assay 
sensitivity varies considerably depending on the source of the DNA used 
for PCR. The fact that the density of Leishmania in the peripheral blood 
is low (Le Fichoux et al., 1999) may lessen the sensitivity of PCR 
detection. ITS1-PCR was shown to be significantly less sensitive in 
diagnosing CVL when DNA used for amplification was purified from 
either buffy coat or whole blood of seropositive dogs, as opposed to 
conjunctiva, spleen and lymph node biopsies (Strauss-Ayali et al., 2004). 
kDNA-PCR is especially useful in regions were only one species, L. 
infantum, causes leishmaniasis in dogs. PCR allowed the identification of 
dogs with both symptomatic, as well as asymptomatic disease, and was 
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useful in identifying infected dogs even before the appearance of 
serum antibodies to leishmanial antigen by ELISA. 
 In our hands, as expected kDNA-PCR using 13A/13B was found 
to be highly sensitive, identifying additional cases missed by either the 
ITS1-and / or mITS1 PCRs (table 3.2 ), the extremely high sensitivity of 
this PCR due to the presence per parasite, of multiple copies of 
kinetoplast DNA (~10,000 copies/cell) in comparison to nuclear DNA 
targets (a few hundred copies for the ITS1 region) (Reale et al., 1999; 
Marfurt et al., 2003; Pravizi et al., 2005). Also the 13A/13B primers, that 
we used, can detect a single or even less than one parasite (Reale et al., 
1999; Vitale et al., 2004). However, nested PCR was shown to improve 
the sensitivity of ITS1 - PCR (Parvizi et al., 2005; Schonian et al., 2003). 
Other parameters in addition to copy number, such as secondary structure 
and amplicon size, can also affect PCR sensitivity (Marchetti et al., 
1998). As we proved shortening the ITS1 fragment amplified from ~300 
bp (ITS1-PCR) to ~200 bp (mITS1-PCR) increased the CVL assay 
sensitivity by three fold from 3 to 9 positive dogs, respectively. One 
advantage that both the mITS1- and ITS1-PCR share is that digestion of 
the amplicon by restriction enzymes, such as HaeIII, is sufficient to 
distinguish between Leishmania species (Schonian et al., 2003). Using 
this PCR-RFLP analysis we successfully identified three and nine 
positive cases detected by ITS1-PCR and mITS1 respectively, they all 
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belonged to L. infantum species (fig. 3.15 and fig. 3.11.B). Using 
kDNA-PCR we could detect Leishmania DNA in eight seronegative 
dogs. This observation is in agreement with previous studies showing that 
PCR can detect parasite DNA in the tissues and/or blood of seronegative 
naturally infected (Solano-Gallego et al., 2001) or experimentally 
infected dogs (Strauss-Ayali et al., 2004). Experimental CVL shows that 
a 2-4 months delay occurs between parasite infection and ELISA 
seroconversion (Abranches et al., 1991; Strauss-Ayali et al., 2004). This 
delay also occurs in natural infections where dogs, parasite positive by 
culture, remain seronegative during long pre-patent periods (Quinnell et 
al., 2001). We are therefore confident that the 10 PCR positive / ELISA 
negative dogs were infected, but had not yet developed a humoral 
immune response against the parasite. Another explanation is that some 
dogs never seroconvert (Silva et al., 2001) and can be considered as 
asymptomatic carriers. The findings that two ELISA positive dogs were 
PCR negative suggests that both assays may be required to accurately 
assess CVL prevalence in endemic areas. Cross-reactions for this ELISA 
using sera from patients with Chagas‟s disease or African sleeping 
sickness are seen, however these diseases are not endemic to our region, 
therefore these two samples can not be considered false positives. This 
discrepancy is most probably that ELISA technique still detects only a 
humoral response to previous contact with the pathogen, so the antibody 
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levels that were detected by ELISA may be due to immunological 
memory rather than to the presence of the parasites in the host, especially 
in areas of endimicity. Another possible explanation for the negative PCR 
reactions in seropositive dogs is that the amount of parasites in peripheral 
blood is low and may fluctuate dramatically over time, especially in 
asymptomatic or oligosymptomatic dogs. ITS1-PCR using buffy coat 
DNA isolated from experimentally infected oligosymptomatic dogs 
showed significant fluctuations in the number of PCR positive dogs over 
a 30 day period following seroconversion (Strauss-Ayali et al., 2004). 
Quinnell et al. (2001) showed that the number of positive parasite 
cultures from bone-marrow peaked in naturally infected dogs two months 
post-seroconversion and then decreased. Similarly real-time PCR analysis 
of parasite load in the spleens of experimentally infected dogs showed 
them to peak one month post-infection and then decline (Strauss-Ayali et 
al., unpublished). On the other hand anti-leishmanial IgG antibody titers 
tend to remain high following seroconversion and may take years to 
decrease to negative levels even following drug treatment and cure.  
       Although a lot of difficulties are associated with the interpretation of 
the sero prevalence data, the main advantage of ELISA test are that large 
numbers of samples can be processed readily and inexpensively, so it 
may provide a standard tool for screening surveys. 
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4.7 GENERAL CONCLUSIONS 
       This study gave an idea about the role of domestic dogs in 
transmitting the disease and also points to the importance of the diagnosis 
and genotyping of CVL in the West Bank.  ITS1 PCR-RFLP used for 
species typing with no intra species variation, while the kDNA PCR-
RFLP, utilizing the primer pair Uni 21/Lmj4, was useful to check the 
polymorphism, in this study the microheterogenity was evident among 
the strains tested. The one strain that appeared more different from others 
was IPT1, a human VL isolated from Tunisia. Thus, parasite 
polymorphism may be attributed to variations among parasites from 
different geographical locations or clusters.  
The data presented in this study indicate a successful attempt to satisfy 
the need for a more sensitive, specific, and rapid test for the diagnosis of   
CVL. 
Serological techniques (e.g. ELISA) alone, which are used to estimate the 
infected dog population (Cardoso et al., 1998), are not  a suitable tools for 
diagnosis of CVL, while PCR offers more accurate results. Indeed, the 
sensitivity and specificity of the PCR assay depends on several factors, 
including PCR primers, DNA extraction methods, source of clinical 
materials (Reithinger et al., 2000) PCR target and PCR target molecular 
size as we proved. The advantage of using blood sampling that it is less 
invasive than bone marrow, spleen, or lymph node aspirate, and samples 
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can be processed readily. This approach on blood samples has proven 
useful for the diagnosis and monitoring of VL in adults and children in 
the Mediterranean region (Sundar and Rai, 2002).  
Further studies are under way in other VL endemic regions, particularly 
in the southern part of the West Bank, to validate the methodology and to 
evaluate the ability of PCR-RFLP to identify other Leishmania species.   
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Recommendation points  
 We recommend to keep screening the potential reservoirs in the 
Jenin area, in order to eradicate and break the leishmaniasis cycle 
in this region, and to prevent or decrease the HVL incidence in the 
area. 
 Continue spraying insecticides to eradicate the vector. 
 Educate the locals by widening their knowledge of the disease 
using leaflets, seminars, and distributing education materials 
targeting the schools, so the people should know more about the 
disease and prevention methods. 
 Establish a database on the disease for planning and evaluation. 
 Regional clinicians must keep in their mind all infectious agents as 
potentials for abdominal enlargement and fever of unknown origin, 
as VL suspected referring them for Al-Quds University, 
Leishmania Laboratory Center for diagnosis as a reference 
laboratory. 
 Palestinian Ministry of health should consider the Leishmania test 
at referred laboratory and implement appropriate control measures 
in endemic areas.  
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